Brisbane's Farmacule will partner Syngenta and QUT to develop sugarcane-derived biofuels. [ + ]

Fast-track grants of $100,000 available to small projects addressing big needs from Bill Gates Foundation. [ + ]

Research Australia report says the source of original research for biotech companies is moving from the public to the private. [ + ]

A Queensland scientist has discovered two genes responsible for developing a form of arthritis known as ankylosing spondylitis, according to research published in the latest edition of

ReWire Therapies can probably boast one of the most impressive groups of company directors to be found in any biotechnology venture in Australia. [ + ]

Adelaide company Oncaidia is developing a novel monoclonal antibody it hopes will target cancer by tracking down the La protein and letting loose a firestorm. [ + ]

As it begins Phase IIa clinical trials, Mesoblast is riding high: its share price is climbing, its market capitalisation is booming and all that promise seems to be coming good. [ + ]

The Molecular Plant Breeding Cooperative Research Centre (MPBCRC) has announced its intention to develop genetically modified (GM) wheat with enhanced tolerance to frost, to help combat concerns over frost damage to crops.

An Australian scientist is leading an international consortium to develop solar-powered bio-reactors and micro-algae as possible sources of energy, which could see some of our future fuel and possibly water needs being generated while absorbing CO₂.

An Australian has been elected president of the International Organization for Standardization (ISO), as it becomes increasingly involved in major global issues such as climate change, security and social responsibility.

Nobel Laureate Professor Barry Marshall is seeking volunteers to take part in a potentially ground-breaking study.

Recent studies have shown that a vacuum, previously thought of as a state of total nothingness, is really filled with energy-hungry ‘virtual particles’ that could interfere with high energy collision experiments.

Researchers have discovered why the Devil Facial Tumour Disease (DFTD) has been so devastating, allowing it to wipe out 90% of some native Tasmanian devil populations.

The Australian government has allocated $62.3 million over the next five years to more than 200 new collaborative research projects.

The Australian government has announced it will provide $3.5 million for projects to commence in 2008 under the Australian Research Council’s (ARC) Linkage International scheme.